Block repetitive activation of sodium channels |
Phenytoin, carbamazepine, oxcarbazepine, lamotrigine, topiramate |
Enhance slow inactivation of sodium channels |
Lacosamide, rufinamide |
Enhance activity of γ-aminobutyric acid (GABAA) receptors |
Phenobarbital, benzodiazepines, clobazam |
Block N-methyl-d-aspartate (NMDA) receptors |
Felbamate |
Block α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors |
Perampanel, topiramate |
Block T-calcium channels |
Ethosuximide, valproate |
Block N- and L-calcium channels |
Lamotrigine, topiramate, zonisamide, valproate |
Modulate H-currents |
Gabapentin, lamotrigine |
Block unique binding sites |
Gabapentin, levetiracetam |
Inhibit carbonic anhydrase |
Topiramate, zonisamide |
Open potassium channels (KCNQ [Kv7]) |
Retigabine |
Inhibit GABA transaminase |
Vigabatrin |
Inhibit GABA reuptake |
Tiagabine |